| Serial Number | 88177424 |
| Word Mark | INNOVENT |
| Filing Date | Thursday, November 1, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 5, 2021 |
| Registration Number | 6236173 |
| Registration Date | Tuesday, January 5, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 20, 2020 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | The non-Latin characters in the mark transliterate to "XIN DA SHENG WU ZHI YAO" and this means "integrity", "action", "bio-pharmaceuticals" in English. |
| NOT AVAILABLE | THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "SHENGWUZHIYAO" |
| Goods and Services | Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemico-pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes |
| Description of Mark | The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT". |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 16, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Innovent Biologics (Suzhou) Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou City 215123 CN |
| Party Name | Innovent Biologics (Suzhou) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Suzhou City 215123 CN |
| Party Name | Innovent Biologics (Suzhou) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou City 215123 CN |
| Event Date | Event Description |
| Monday, November 5, 2018 | NEW APPLICATION ENTERED |
| Friday, November 16, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 17, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, February 7, 2019 | ASSIGNED TO EXAMINER |
| Monday, March 11, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, March 11, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, March 11, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, August 23, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 23, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 24, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 26, 2020 | FINAL REFUSAL WRITTEN |
| Wednesday, February 26, 2020 | FINAL REFUSAL E-MAILED |
| Wednesday, February 26, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, March 12, 2020 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, March 12, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 13, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 19, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 1, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 21, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 21, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 16, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, July 24, 2020 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Wednesday, September 9, 2020 | ASSIGNED TO PETITION STAFF |
| Friday, September 11, 2020 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Friday, September 11, 2020 | ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED |
| Thursday, September 17, 2020 | NOTICE OF ALLOWANCE CANCELLED |
| Thursday, September 17, 2020 | 1(B) BASIS DELETED; NEW BASIS REQUESTED |
| Wednesday, September 30, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 20, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 20, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 5, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Monday, January 5, 2026 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |